• CONNECT
BioAce Health Therapeutics
  • About Us
    • At A Glance
    • Partners
    • Contact
  • Science
    • Approach
    • Technology
    • Pipeline
    • Clinical Trials
    • Scientific Publications
  • News Center
    • Media Resources
  • Careers
  • Pharmaceutical
  • Veterinary

Science

Scientific Publications

Check out the latest publications and poster presentations related to our science.

December 2019

American Society of Hematology (ASH) Dec. 2019 –Reitec Anti-BCMA GMAR T Cells Show Tumor Specific Killing Against Primary Multiple Myeloma Cells

December 2019

American Society of Hematology (ASH) Dec. 2019 – Preclinical Evaluation of GMART-819, Targeting FLT3, in Acute Myeloid Leukemia

April 2019

American Association for Cancer Research (AACR) April 2019 – GMAR TTM Targeting CD70 For RCC

December 2018

American Society of Hematology (ASH) Dec. 2018 – GMART-819, An Reitec FLT3 GMAR T Therapy Possessing An Off-Switch for the Treatment of Acute Myeloid Leukemia

December 2018

American Society of Hematology (ASH) Dec. 2018 – SKBT42 PALL and CALM Studies

June 2018

A Versatile Safeguard for Chimeric Antigen Receptor T-Cell Immunotherapies Valton J, Guyot V, Boldajipour B, et al.

Scientific Reports
May 2018

American Society of Gene and Cell Therapy (ASGCT) May 2018 – Development of an In Vitro Cynomolgus Macaque Reitec GMAR T Cell Platform

news

Stay informed about our latest news and developments.

Learn
More

join our team

Interested in learning about job opportunities at BioAce ?

Learn
More

BioAce Health Therapeutics

Connect:

601 13th St, Suite 810
Washington, DC 20005

View map | CONTACT US

Explore:

  • About Us
  • Science
  • Careers
  • Pharmaceutical
  • Veterinary
  • TERMS OF USE
  • PRIVACY POLICY

© 2025 BioAce Health Therapeutics